Most Active Stocks

PAYTM
BSE
CDSL
COCHINSHIP
RPOWER
TANLA
INFY
OIL
ROUTE
HDFCBANK
BAJFINANCE
TCS
ONGC
BHARTIARTL
SWSOLAR
WOCKPHARMA
MAZDOCK
NAVA
GRSE
ASIANPAINT

Aarti Drugs Limited

Drug Manufacturers - Specialty & Generic | Healthcare

Company Overview

Aarti Drugs Limited, through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally. The company offers aceclofenac, celecoxib, diclofenac sodium, diclodenac potassium, diclofenac diethylamine, diclofenac resinate, diclofenac epolamine, nimesulide, ciprofloxacin HCL, enrofloxacin base, gatifloxacin sesquihydrate, levofloxacin base, moxifloxacin, norfloxacin, ofloxacin, metronidazole benzoate, ornidazole, secnidazole, tinidazole, clopidogrel bisulphate, ticlopidine HCL, metformin HCL, pioglitazone HCL, teneligliptin, vildagliptin, fluconazole, ketoconazole, tolnaftate, zolpidem tartrate, niacin, raloxifene HCL, and acamprosate. It also provides benzene sulphonyl chloride, benzene sulphonic acid, benzene sulphonic acid methyl ester, sodium benzene sulfinate, para toluene sulphonyl chloride, methyl para toluenesulfonate, sodium para toluenesulfinate, para chlorobenzenesulfonyl chloride, formamide, calcium fluoride, potasium formate, benzenesulfonamide, ethyl p- toluenesulfonate, N,N',N'-tris-(4-toluene sulfonyl)-diethylenetriamine, ortho para toluene sulfonamides, ortho para toluene sulfonamides acid methyl ester, para chlorobenznesulfonamide, para toluenesulfonyl hydrazide, para toluenesulfonamide, and sodium benzenesulfonate. In addition, it offers pharma intermediate products, which includes Celecoxib, Ciprofloxacin, Clopidogrel, Diclofenac, Ketoconazole, Nimesulide, Raloxifene, Tinidazole, and Zolpidem. Further, the company develops drugs for the antioxidant, antifungal, cardiovascular, and antidiabetic therapeutic areas. The company was incorporated in 1984 and is headquartered in Mumbai, India.

Key Information

Market Cap

43557036032

Current Price

475.5

52 Week Range

312.0 - 635.0

Previous Close

466.5

Open

468.8

Contact Details

Address

Mahendra Industrial Estate, Ground Floor Road No. 29, Plot No. 109-D Sion (East), Mumbai, 400 022, India

Phone

+91-22240-19025

Fax

+91-22240-73462

Financials

Day Low

462.4

Day High

476.7

Dividend Yield

0.21

PE Ratio

25.997812

Earnings Per Share

18.29

Beta

0.412

EBITDA

2870599936

Book Value

149.836

EPS

23.2

Company Officers

Name Title Age Year Born
Mr. Prakash Moreshwar Patil Chairman, MD, CEO & Head of BR 77 1947
Mr. Harshit Manila Savla Joint MD & Executive Director 62 1962
Mr. Adhish Prakash Patil CFO & COO 41 1983
Mr. Rushikesh Vivek Deole Company Secretary & Compliance Officer - -
Mr. Harit Pragji Shah Whole-Time Director 61 1963
Mr. Uday Moreshwar Patil Whole-Time Director 61 1963
Mr. Rashesh Chandrakant Gogri MD & Executive Director 50 1974
Mr. Dhanaji L. Kakade Vice President of Technical - -
Mr. Vishwa Harshit Savla Managing Director of the Pinnacle Life Science Private Limited - -

Company Details

Stock History